GLI1 and cancer: Non-canonical Gli activation independent of Shh activation has also been noted in many cancer cells types, owing to stimulation by other oncogenic signaling pathways such as transforming growth factor β (TGF-β), epidermal growth factor receptor (EGFR), RAS, and AKT/PI3K [28–32].